注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
Pyxis Oncology Inc是一家腫瘤學公司。該公司專注於開發下一代療法,以針對難以治療的癌症並改善患者的生活質量。該公司利用其完全整合的研究、開發和商業能力來建立多元化的下一代治療產品組合。該公司的治療候選藥物旨在直接殺死腫瘤細胞並解決癌症造成的潛在病理,使其無法控制增殖和免疫逃避。該公司已開發出廣泛的新型抗體藥物偶聯物(ADC)、免疫腫瘤學(IO)、候選產品和單克隆抗體(mAb)產品組合,以及作為單一療法並與其他療法相結合的臨床前發現項目。該公司產品管線為PYX-201和PYX-106。
名稱 | 年齡 | 成立於 | 主旨 |
---|---|---|---|
Darren S. Cline | 60 | 2021 | Independent Director |
Robert Baffi | - | - | Member of Technical Advisory Board |
Michael Sun | - | - | Member of Technical Advisory Board |
Thomas Civik | 55 | 2021 | Independent Director |
Freda C. Lewis-Hall | 69 | 2021 | Independent Director |
Jason J. Luke | - | - | Member of Clinical & Translational Medicine Advisory Board |
Virgil Bryan Lawlis | - | - | Member of Technical Advisory Board |
Anthony W. Tolcher | - | 2021 | Member of Clinical & Translational Medicine Advisory Board |
Christopher O’Donnell | 54 | 2021 | Member of Technical Advisory Board |
Morris Rosenberg | - | - | Chairperson of Technical Advisory Board |
Jakob Dupont | 59 | 2023 | Independent Director |
Rachel Wallach Humphrey | 63 | 2022 | Independent Director |
Elliott M. Levy | 66 | 2023 | Member of Clinical & Translational Medicine Advisory Board |
Patricia LoRusso | - | 2023 | Member of Clinical & Translational Medicine Advisory Board |
Giulio Draetta | - | 2023 | Member of Clinical & Translational Medicine Advisory Board |
Glenn A. Miller | - | 2023 | Member of Clinical & Translational Medicine Advisory Board |
Paul A. Bunn | - | 2023 | Member of Clinical & Translational Medicine Advisory Board |
Santhosh Palani | 40 | 2024 | Independent Director |
Lara S. Sullivan | - | 2019 | CEO, President & Director |
John L. Flavin | 53 | 2019 | Independent Chairman |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核